Boston Scientific Corporation (BSX) vs HCA Healthcare, Inc. (HCA)
HCA leads on 9 of 15 compared metrics.
A side-by-side comparison of Boston Scientific Corporation and HCA Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BSX
Boston Scientific Corporation
$46.92Healthcare
HCA
HCA Healthcare, Inc.
$396.93Healthcare
Total return — BSX vs HCA
growth of $100 · last 15yBSX +530.6%HCA +1179.6%HCA compounded faster
BSX HCA
BSX vs HCA: by the numbers
- •HCA is the larger company ($88.05B vs $69.74B market cap).
- •HCA trades at the lower earnings multiple (13.65 vs 19.71 P/E).
- •BSX converts more revenue to profit (17.24% vs 8.89% net margin).
- •BSX grew revenue faster over the past five years (15.29% vs 7.73% CAGR).
- •HCA pays a dividend (0.76% yield) while BSX does not currently pay one.
Which is better, BSX or HCA?
Metric tally: BSX 6 · HCA 9It depends on what you're optimizing for:
ValueHCA(lower P/E)
GrowthBSX(faster 5Y revenue CAGR)
QualityHCA(higher ROIC)
Metrics side by side
Valuation
| Metric | BSX | HCA |
|---|---|---|
| P/E ratio | 19.71 | 13.65● |
| Forward P/E | 12.60 | 11.96● |
| P/S ratio | 3.40 | 1.18● |
| P/B ratio | 2.71 | — |
| PEG ratio | 0.88 | 0.56● |
| EV / EBITDA | 14.07 | 8.86● |
| FCF yield | 4.91% | 8.81%● |
Profitability
| Metric | BSX | HCA |
|---|---|---|
| Gross margin | 70.41%● | 34.92% |
| Operating margin | 20.12%● | 15.67% |
| Net margin | 17.24%● | 8.89% |
| ROE | 13.74%● | -112.56% |
| ROIC | 8.78% | 18.53%● |
Dividends
| Metric | BSX | HCA |
|---|---|---|
| Dividend yield | — | 0.76% |
| Payout ratio | — | 10.48% |
Growth (annualized)
| Metric | BSX | HCA |
|---|---|---|
| Revenue CAGR (5Y) | 15.29%● | 7.73% |
| EPS CAGR (5Y) | -8.67% | 20.90%● |
| FCF CAGR (5Y) | 19.89%● | 1.92% |
| Total return CAGR (5Y) | 1.86% | 14.89%● |
Frequently asked
- Which is better, BSX or HCA?
- It depends on your goal. value: HCA (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: HCA (higher ROIC). Across all compared metrics, HCA leads 9 to 6.
- Is BSX or HCA cheaper?
- On trailing earnings, HCA is cheaper: BSX trades at a 19.71 P/E and HCA at 13.65.
- Which has grown faster, BSX or HCA?
- Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus HCA at 7.73%.
- Does BSX or HCA pay a bigger dividend?
- HCA pays a dividend (0.76% yield) while BSX does not currently pay one.
- Is BSX or HCA more profitable?
- BSX runs the higher net margin — BSX at 17.24% versus HCA at 8.89%.
- Which has been the better investment, BSX or HCA?
- Over the past 10-year, HCA delivered the higher annualized total return — BSX at 7.47% versus HCA at 18.63%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioHCA Healthcare P/E ratioBoston Scientific dividend yieldHCA Healthcare dividend yieldBoston Scientific ROEHCA Healthcare ROEBoston Scientific operating marginHCA Healthcare operating marginBoston Scientific revenue growthHCA Healthcare revenue growthBoston Scientific free cash flowHCA Healthcare free cash flow
Boston Scientific & HCA Healthcare appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.